SSBP2 is an in vivo tumor suppressor and regulator of LDB1 stability

Oncogene

Volumn 29, Issue 21, 2010, Pages 3044-3053

  Wang, Y ^a   Klumpp, S ^a   Amin, H M ^a   Liang, H ^a   Li, J ^a   Estrov, Z ^a   Zweidler Mckay, P ^a   Brandt, S J ^b   Agulnick, A ^c   Nagarajan, L ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c Georgia Biobusiness Center   (United States)

Author keywords

LIM code; Lymphoma; Null mouse; P53; SSBP2; Tumor suppressor

Indexed keywords

PROTEIN P53; SINGLE STRANDED DNA BINDING PROTEIN; SINGLE STRANDED DNA BINDING PROTEIN 2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B CELL LYMPHOMA; CANCER INHIBITION; CANCER STAGING; CARCINOGENESIS; CARCINOMA; CHROMOSOME 5Q; CHROMOSOME LOSS; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE ISOLATION; GENE TARGETING; GENETIC TRANSCRIPTION; IN VIVO STUDY; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN METABOLISM; PROTEIN STABILITY; T LYMPHOCYTE; THYMOCYTE; THYMUS; UPREGULATION;

ANIMALS; CELL DIFFERENTIATION; CRICETINAE; DNA-BINDING PROTEINS; GENES, LETHAL; GENES, TUMOR SUPPRESSOR; HUMANS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; T-LYMPHOCYTES; THYMUS GLAND; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 77952956974     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2010.78     Document Type: Article

References (38)

1. Agulnick AD, Taira M, Breen JJ, Tanaka T, Dawid IB, Westphal H. (1996). Interactions of the LIM-domain-binding factor Ldb1 with LIM homeodomain proteins. Nature 384: 270-272.
2. Aoyama M, Ozaki T, Inuzuka H, Tomotsune D, Hirato J, Okamoto Y et al. (2005). LMO3 interacts with neuronal transcription factor, HEN2, and acts as an oncogene in neuroblastoma. Cancer Res 65: 4587-4597.
3. Bach I, Rodriguez-Esteban C, Carriere C, Bhushan A, Krones A, Rose DW et al. (1999). RLIM inhibits functional activity of LIM homeodomain transcription factors via recruitment of the histone deacetylase complex. Nat Genet 22: 394-399.
4. Baseta JG, Stutman O. (2000). TNF regulates thymocyte production by apoptosis and proliferation of the triple negative (CD3-CD4-CD8-) subset. J Immunol 165: 5621-5630.
5. Cai Y, Xu Z, Nagarajan L, Brandt SJ. (2008). Single-stranded DNA-binding proteins regulate the abundance and function of the LIM-homeodomain transcription factor LHX2 in pituitary cells. Biochem Biophys Res Commun 373: 303-308.
6. Capron C, Lecluse Y, Kaushik AL, Foudi A, Lacout C, Sekkai D et al. (2006). The SCL relative LYL-1 is required for fetal and adult hematopoietic stem cell function and B-cell differentiation. Blood 107: 4678-4686.
7. Castro P, Liang H, Liang JC, Nagarajan L. (2002). A novel, evolutionarily conserved gene family with putative sequence-specific single-stranded DNA-binding activity. Genomics 80: 78-85.
8. Cerretini R, Noriega MF, Narbaitz M, Slavutsky I. (2006). New chromosome abnormalities and lack of BCL-6 gene rearrangements in Argentinean diffuse large B-cell lymphomas. Eur J Haematol 76: 284-293.
9. Chen L, Segal D, Hukriede NA, Podtelejnikov AV, Bayarsaihan D, Kennison JA et al. (2002). Ssdp proteins interact with the LIM-domain-binding protein Ldb1 to regulate development. Proc Natl Acad Sci USA 99: 14320-14325.
10. Dave SS, Wright G, Tan B, Rosenwald A, Gascoyne RD, Chan WC et al. (2004). Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N Engl J Med 351: 2159-2169.
11. Fleisig HB, Orazio NI, Liang H, Tyler AF, Adams HP, Weitzman MD et al. (2007). Adenoviral E1B55K oncoprotein sequesters candidate leukemia suppressor sequence-specific single-stranded DNA-bind-ing protein 2 into aggresomes. Oncogene 26: 4797-4805.
12. Goardon N, Lambert JA, Rodriguez P, Nissaire P, Herblot S, Thibault P et al. (2006). ETO2 coordinates cellular proliferation and differentiation during erythropoiesis. EMBO J 25: 357-366.
13. Gungor C, Taniguchi-Ishigaki N, Ma H, Drung A, Tursun B, Ostendorff HP et al. (2007). Proteasomal selection of multiprotein complexes recruited by LIM homeodomain transcription factors. Proc Natl Acad Sci USA 104: 15000-15005.
14. Haines BB, Ryu CJ, Chang S, Protopopov A, Luch A, Kang YH et al. (2006). Block of T cell development in P53-deficient mice accelerates development of lymphomas with characteristic RAG-dependent cytogenetic alterations. Cancer Cell 9: 109-120.
15. Haks MC, Krimpenfort P, van den Brakel JH, Kruisbeek AM. (1999). Pre-TCR signaling and inactivation of p53 induces crucial cell survival pathways in pre-T cells. Immunity 11: 91-101.
16. Jacks T, Remington L, Williams BO, Schmitt EM, Halachmi S, Bronson RT et al. (1994). Tumor spectrum analysis in p53-mutant mice. Curr Biol 4: 1-7.
17. Johnsen SA, Gungor C, Prenzel T, Riethdorf S, Riethdorf L, Taniguchi-Ishigaki N et al. (2009). Regulation of estrogen-dependent transcription by the LIM cofactors CLIM and RLIM in breast cancer. Cancer Res 69: 128-136.
18. Koch JG, Gu X, Han Y, El-Naggar AK, Olson MV, Medina D et al. (2007). Mammary tumor modifiers in BALB/cJ mice heterozygous for p53. Mamm Genome 18: 300-309.
19. Lecuyer E, Lariviere S, Sincennes MC, Haman A, Lahlil R, Todorova M et al. (2007). Protein stability and transcription factor complex assembly determined by the SCL-LMO2 interaction. J Biol Chem 282: 33649-33658.
20. Liang H, Samanta S, Nagarajan L. (2005). SSBP2, a candidate tumor suppressor gene, induces growth arrest and differentiation of myeloid leukemia cells. Oncogene 24: 2625-2634.
21. Liu JW, Nagpal JK, Sun W, Lee J, Kim MS, Ostrow KL et al. (2008). ssDNA-binding protein 2 is frequently hypermethylated and suppresses cell growth in human prostate cancer. Clin Cancer Res 14: 3754-3760.
22. Majeti R, Becker MW, Tian Q, Lee TL, Yan X, Liu R et al. (2009). Dysregulated gene expression networks in human acute myelogen-ous leukemia stem cells. Proc Natl Acad Sci USA 106: 3396-3401.
23. Murre C. (2005). Helix-loop-helix proteins and lymphocyte development. Nat Immunol 6: 1079-1086.
24. Nam CH, Rabbitts TH. (2006). The role of LMO2 in development and in T cell leukemia after chromosomal translocation or retroviral insertion. Mol Ther 13: 15-25.
25. Natkunam Y, Farinha P, Hsi ED, Hans CP, Tibshirani R, Sehn LH et al. (2008). LMO2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy with and without rituximab. J Clin Oncol 26: 447-454.
26. O'Neil J, Shank J, Cusson N, Murre C, Kelliher M. (2004). TAL1/SCL induces leukemia by inhibiting the transcriptional activity of E47/HEB. Cancer Cell 5: 587-596.
27. Poitras JL, Dal Cin P, Aster JC, Deangelo DJ, Morton CC. (2008). Novel SSBP2-JAK2 fusion gene resulting from a t(5;9)(q14.1;p24.1) in pre-B acute lymphocytic leukemia. Genes Chromosomes Cancer 47: 884-889.
28. Qian Z, Fernald AA, Godley LA, Larson RA, Le Beau MM. (2002). Expression profiling of CD34+ hematopoietic stem/progenitor cells reveals distinct subtypes of therapy-related acute myeloid leukemia. Proc Natl Acad Sci USA 99: 14925-14930.
29. Rothenberg EV. (2007a). Cell lineage regulators in B and T cell development. Nat Immunol 8: 441-444.
30. Rothenberg EV. (2007b). Regulatory factors for initial T lymphocyte lineage specification. Curr Opin Hematol 14: 322-329.
31. Smith KS, Rhee JW, Naumovski L, Cleary ML. (1999). Disrupted differentiation and oncogenic transformation of lymphoid progenitors in E2A-HLF transgenic mice. Mol Cell Biol 19: 4443-4451.
32. Sum EY, Segara D, Duscio B, Bath ML, Field AS, Sutherland RL et al. (2005). Overexpression of LMO4 induces mammary hyper-plasia, promotes cell invasion, and is a predictor of poor outcome in breast cancer. Proc Natl Acad Sci USA 102: 7659-7664.
33. Tremblay M, Herblot S, Lecuyer E, Hoang T. (2003). Regulation of pT alpha gene expression by a dosage of E2A, HEB, and SCL. J Biol Chem 278: 12680-12687.
34. Uren AG, Kool J, Matentzoglu K, de Ridder J, Mattison J, van Uitert M. (2008). Large scale mutagenesis in p19(ARF)-and p53-deficient mice identifies cancer genes and their collaborative networks. Cell 133: 727-741.
35. van Meyel DJ, Thomas JB, Agulnick AD. (2003). Ssdp proteins bind to LIM-interacting co-factors and regulate the activity of LIM-homeodomain protein complexes in vivo. Development 130: 1915-1925.
36. Wu HK, Heng HH, Siderovski DP, Dong WF, Okuno Y, Shi XM et al. (1996). Identification of a human LIM-Hox gene, hLH-2, aberrantly expressed in chronic myelogenous leukaemia and located on 9q33-34.1. Oncogene 12: 1205-1212.
37. Xu Z, Meng X, Cai Y, Liang H, Nagarajan L, Brandt SJ. (2007). Single-stranded DNA-binding proteins regulate the abundance of LIM domain and LIM domain-binding proteins. Genes Dev 21: 942-955.
38. Zhang XB, Beard BC, Trobridge GD, Wood BL, Sale GE, Sud R et al. (2008). High incidence of leukemia in large animals after stem cell gene therapy with a HOXB4-expressing retroviral vector. J Clin Invest 118: 1502-1510.